p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation

Molecular and Cellular Biology

Volumn 35, Issue 7, 2015, Pages 1223-1237

  Lu, Jia Yang ^a   Sewer, Marion B ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CORTICOTROPIN; CYCLIC AMP; CYTOCHROME P450 17; CYTOCHROME P450 17A1; DACTINOMYCIN; EXORIBONUCLEASE; GLUCOCORTICOID; HYDROCORTISONE; ISOBUTYLMETHYLXANTHINE; MELANOCORTIN 2 RECEPTOR; PHOSPHODIESTERASE; PHOSPHODIESTERASE 11A; PHOSPHODIESTERASE 2A; PHOSPHODIESTERASE 4A; POLYADENYLIC ACID; PRASTERONE; PROTEIN P54; SMALL NUCLEAR RNA; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG; CYCLIC AMP PHOSPHODIESTERASE; ISOPROTEIN; NONO PROTEIN, HUMAN; NUCLEAR MATRIX PROTEIN; OCTAMER TRANSCRIPTION FACTOR; RNA BINDING PROTEIN;

ADRENAL CORTEX CELL; AFFINITY CHROMATOGRAPHY; ALTERNATIVE RNA SPLICING; AMINO ACID METABOLISM; ARTICLE; BIOSYNTHESIS; CELLULAR DISTRIBUTION; CYTOPLASM; DOWN REGULATION; EXON; GENE EXPRESSION; GENE ONTOLOGY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIPID METABOLISM; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; SEQUENCE HOMOLOGY; STEROID METABOLISM; STEROIDOGENESIS; UPREGULATION; WESTERN BLOTTING; WILD TYPE; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN DEGRADATION; RNA SPLICING;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; CELL LINE; CYCLIC AMP; GENE EXPRESSION REGULATION; GENE SILENCING; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; NUCLEAR MATRIX-ASSOCIATED PROTEINS; OCTAMER TRANSCRIPTION FACTORS; PROTEIN ISOFORMS; PROTEOLYSIS; RNA SPLICING; RNA-BINDING PROTEINS;

EID: 84924872930     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00993-14     Document Type: Article

References (54)

1. Yang Y-S, Hanke JH, Carayannopoulos L, Craft CM, Capra JD, Tucker PW. 1993. NonO, a non-POU-domain-containing, octamer-binding protein, is the mammalian homolog of Drosophila nonAdiss. Mol Cell Biol 13:5593-5603.
2. Dong B, Horowitz DS, Kobayashi R, Krainer AR. 1993. Purification and cDNA cloning of HeLa cell p54nrb, a nuclear protein with two RNA recognition motifs and extensive homology to human splicing factor PSF and Drosophila NONA/BJ6. Nucleic Acids Res 21:4085-4092. http://dx.doi.org/10.1093/nar/21.17.4085.
3. Shav-Tal Y, Zipori D. 2002. PSF and p54(nrb)/NonO-multi-functional nuclear proteins. FEBS Lett 531:109-114. http://dx.doi.org/10.1016/S0014-5793(02)03447-6.
4. Emili A, Shales M, McCracken S, Xie W, Tucker PW, Kobayashi R, Blencowe BJ, Ingles CJ. 2002. Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD. RNA 8:1102-1111. http://dx.doi.org/10.1017/S1355838202025037.
5. Patton JG, Porro EB, Galceran J, Tempst P, Nadal-Ginard B. 1993. Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev 7:393-406. http://dx.doi.org/10.1101/gad.7.3.393.
6. DeCerbo J, Carmichael GG. 2005. Retention and repression: fates of hyperedited RNAs in the nucleus. Curr Opin Cell Biol 17:302-308. http://dx.doi.org/10.1016/j.ceb.2005.04.008.
7. Passon DM, Lee M, Rackham O, Stanley WA, Sadowska A, Filipovska A, Fox AH, Bond CS. 2012. Structure of the heterodimer of human NONO and paraspeckle protein component 1 and analysis of its role in subnuclear body formation. Proc Natl Acad Sci U S A 109:4846-4850. http://dx.doi.org/10.1073/pnas.1120792109.
8. nrb/NonO. Mol Cell Biol 17:377-686.
9. Yang Y-S, Yang M-C W, Tucker PW, Capra JD. 1997. NonO enhances the association of many DNA-binding proteins to their targets. Nucleic Acids Res 25:2284-2292. http://dx.doi.org/10.1093/nar/25.12.2284.
10. Mathur M, Tucker PW, Samuels HH. 2001. PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol Cell Biol 21:2298-2311. http://dx.doi.org/10.1128/MCB.21.7.2298-2311.2001.
11. Ishitani K, Yoshida T, Kitagawa H, Ohta H, Nozawa S, Kato S. 2003. p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor. Biochem Biophys Res Commun 306:660-665. http://dx.doi.org/10.1016/S0006-291X(03)01021-0.
12. Zhang Z, Carmichael GG. 2001. The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 106:465-475. http://dx.doi.org/10.1016/S0092-8674(01)00466-4.
13. Hisada-Ishii S, Ebihara M, Kobayashi N, Kitagawa Y. 2007. Bipartite nuclear localization signal of matrin 3 is essential for vertebrate cells. Biochem Biophys Res Commun 354:72-76. http://dx.doi.org/10.1016/j.bbrc.2006.12.191.
14. Straub T, Grue P, Uhse A, Lisby M, Knudsen BR, Tange TO, Westergaard O, Boege F. 1998. The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction. J Biol Chem 273:26261-26264. http://dx.doi.org/10.1074/jbc.273.41.26261.
15. Fox AH, Bond CS, Lamond AI. 2005. p54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an RNA-dependent manner. Mol Biol Cell 16:5304-5315. http://dx.doi.org/10.1091/mbc. E05-06-0587.
16. Amelio AL, Miraglia LJ, Conkright JJ, Mercer BA, Batalov S, Cavett V, Orth AP, Busby J, Hogenesch JB, Conkright MD. 2007. A coactivator trap identifies NONO (p54nrb) as a component of the cAMP-signaling pathway. Proc Natl Acad Sci USA 104:20314-20319. http://dx.doi.org/10.1073/pnas.0707999105.
17. Pavao M, Huang Y-H, Hafer L, Moreland R, Traish A. 2001. Immunodetection of nmt55/p54nrb isoforms in human breast cancer. BMC Cancer 1:15. http://dx.doi.org/10.1186/1471-2407-1-15.
18. Hallier M, Tavitian A, Moreau-Gachelin F. 1996. The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54. J Biol Chem 271:11177-11181. http://dx.doi.org/10.1074/jbc.271.19.11177.
19. Sewer MB, Dammer EB, Jagarlapudi S. 2007. Transcriptional regulation of adrenocortical steroidogenic gene expression. Drug Metab Rev 39:371-388. http://dx.doi.org/10.1080/03602530701498828.
20. Sewer MB, Waterman MR. 2003. ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex. Microsc Res Tech 61:300-307. http://dx.doi.org/10.1002/jemt.10339.
21. Dammer EB, Leon A, Sewer MB. 2007. Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3',5'-monophosphate-dependent cytochrome P450c17 transcription rate. Mol Endocrinol 21:415-438. http://dx.doi.org/10.1210/me.2006-0361.
22. Sewer MB, Nguyen V, Huang C-J, Tucker PW, Kagawa N, Waterman MR. 2002. Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation between p54nrb/NonO, PSF and SF-1, a complex which also participates in repression of transcription. Endocrinology 143:1280-1290. http://dx.doi.org/10.1210/endo.143.4.8748.
23. Bender AT, Beavo JA. 2006. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488-520. http://dx.doi.org/10.1124/pr.58.3.5.
24. Omori K, Kotera J. 2007. Overview of PDEs and their regulation. Circ Res 100:309-327. http://dx.doi.org/10.1161/01.RES.0000256354.95791.f1.
25. Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP, Keil M, Heyerdahl S, Matyakhina L, Libe R, Fratticci A, Kirschner LS, Cramer K, Gaillard RC, Bertagna X, Carney JA, Bertherat J, Bossis I, Stratakis CA. 2006. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 38:794-800. http://dx.doi.org/10.1038/ng1809.
26. Parker KL, Rice DA, Lala DS, Ikeda Y, Luo X, Wong M, Bakke M, Zhao L, Frigeri C, Hanley NA, Stallings N, Schimmer BP. 2002. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog Horm Res 57:19-36. http://dx.doi.org/10.1210/rp.57.1.19.
27. Schimmer BP, White PC. 2010. Steroidogenic factor 1: its roles in differentiation, development, and disease. Mol Endocrinol 24:1322-1337. http://dx.doi.org/10.1210/me.2009-0519.
28. Bassett MH, Suzuki T, Sasano H, De Vries CJ, Jimenez PT, Carr BR, Rainey WE. 2004. The orphan nuclear receptor NGFIB regulates transcription of 3beta-hydroxysteroid dehydrogenase. implications for the control of adrenal functional zonation. J Biol Chem 279:37622-37630. http://dx.doi.org/10.1074/jbc. M405431200.
29. Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE. 2004. The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol 18:279-290. http://dx.doi.org/10.1210/me.2003-0005.
30. Boikos SA, Horvath A, Heyerdahl S, Stein E, Robinson-White A, Bossis I, Bertherat J, Carney JA, Stratakis CA. 2008. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions. Horm Metab Res 40:347-353. http://dx.doi.org/10.1055/s-2008-1076694.
31. Faucz FR, Horvath A, Rothenbuhler A, Almeida MQ, Libe R, Raffin-Sanson ML, Bertherat J, Carraro DM, Soares FA, Molina Gde C, Campos AH, Alexandre RB, Bendhack ML, Nesterova M, Stratakis CA. 2011. Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer. J Clin Endocrinol Metab 96:E135-E140. http://dx.doi.org/10.1210/jc.2010-1655.
32. Libe R, Horvath A, Vezzosi D, Fratticci A, Coste J, Perlemoine K, Ragazzon B, Guillaud-Bataille M, Groussin L, Clauser E, Raffin-Sanson ML, Siegel J, Moran J, Drori-Herishanu L, Faucz FR, Lodish M, Nesterova M, Bertagna X, Bertherat J, Stratakis CA. 2011. Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype. J Clin Endocrinol Metab 96:E208-E214. http://dx.doi.org/10.1210/jc.2010-1704.
33. Goldstein JL, Brown MS. 2009. The LDL receptor. Arterioscler Thromb Vasc Biol 29:431-438. http://dx.doi.org/10.1161/ATVBAHA.108.179564.
34. Oscai LB, Essig DA, Palmer WK. 1990. Lipase regulation of muscle triglyceride hydrolysis. J Appl Physiol 69:1571-1577.
35. Fayard E, Auwerx J, Schoonjans K. 2004. LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol 14:250-260. http://dx.doi.org/10.1016/j.tcb.2004.03.008.
36. Izumi H, McCloskey A, Shinmyozu K, Ohno M. 2014. p54nrb/NONO and PSF promoteUsnRNA nuclear export by accelerating its export complex assembly. Nucleic Acids Res 42:3998-4007. http://dx.doi.org/10.1093/nar/gkt1365.
37. West S, Gromak N, Proudfoot NJ. 2004. Human 5'→3' exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites. Nature 432:522-525. http://dx.doi.org/10.1038/nature03035.
38. Kaneko S, Rozenblatt-Rosen O, Meyerson M, Manley JL. 2007. The multifunctional protein p54nrb/PSF recruits the exonuclease XRN2 to facilitate pre-mRNA 3' processing and transcription termination. Genes Dev 21:1779-1789. http://dx.doi.org/10.1101/gad.1565207.
39. Bianconcini A, Lupo A, Capone S, Quadro L, Monti M, Zurlo D, Fucci A, Sabatino L, Brunetti A, Chiefari E, Gottesman ME, Blaner WS, Colantuoni V. 2009. Transcriptional activity of the murine retinolbinding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1). Int J Biochem Cell Biol 41:2189-2203. http://dx.doi.org/10.1016/j.biocel.2009.04.011.
40. Ong SA, Tan JJ, Tew WL, Chen KS. 2011. Rasd1 modulates the coactivator function of NonO in the cyclic AMP pathway. PLoS One 6:e24401. http://dx.doi.org/10.1371/journal.pone.0024401.
41. Basu A, Dong B, Krainer AR, Howe CC. 1997. The intracisternal A-particle proximal enhancer-binding protein activates transcription and is identical to the RNA- and DNA-binding protein p54nrb/NonO. Mol Cell Biol 17:677-686.
42. Rosonina E, Ip JY, Calarco JA, Bakowski MA, Emili A, McCracken S, Tucker P, Ingles CJ, Blencowe BJ. 2005. Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo. Mol Cell Biol 25:6734-6746. http://dx.doi.org/10.1128/MCB.25.15.6734-6746.2005.
43. Kameoka S, Duque P, Konarska MM. 2004. p54(nrb) associates with the 5' splice site within large transcription/splicing complexes. EMBO J 23:1782-1791. http://dx.doi.org/10.1038/sj.emboj.7600187.
44. Yadav SP, Hao H, Yang HJ, Kautzmann MA, Brooks M, Nellissery J, Klocke B, Seifert M, Swaroop A. 2014. The transcription-splicing protein NonO/p54nrb and three NonO-interacting proteins bind to distal enhancer region and augment rhodopsin expression. Hum Mol Genet 23:2132-2144. http://dx.doi.org/10.1093/hmg/ddt609.
45. Marko M, Leichter M, Patrinou-Georgoula M, Guialis A. 2010. hnRNP Minteracts with PSF and p54(nrb) and co-localizes within defined nuclear structures. Exp Cell Res 316:390-400. http://dx.doi.org/10.1016/j.yexcr.2009.10.021.
46. Xu K, Yang L, Zhao D, Wu Y, Qi H. 2014. AKAP3 synthesis is mediated by RNA binding proteins and PKA signaling during mouse spermatogenesis. Biol Reprod 90:119. http://dx.doi.org/10.1095/biolreprod.113.116111.
47. Horvath A, Giatzakis C, Tsang K, Greene E, Osorio P, Boikos S, Libe R, Patronas Y, Robinson-White A, Remmers E, Bertherat J, Nesterova M, Stratakis CA. 2008. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet 16:1245-1253. http://dx.doi.org/10.1038/ejhg.2008.85.
48. Horvath A, Mericq V, Stratakis CA. 2008. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med 358:750-752. http://dx.doi.org/10.1056/NEJMc0706182.
49. Arnaud-Lopez L, Usala G, Ceresini G, Mitchell BD, Pilia MG, Piras MG, Sestu N, Maschio A, Busonero F, Albai G, Dei M, Lai S, Mulas A, Crisponi L, Tanaka T, Bandinelli S, Guralnik JM, Loi A, Balaci L, Sole G, Prinzis A, Mariotti S, Shuldiner AR, Cao A, Schlessinger D, Uda M, Abecasis GR, Nagaraja R, Sanna S, Naitza S. 2008. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. AmJHumGenet 82:1270-1280. http://dx.doi.org/10.1016/j.ajhg.2008.04.019.
50. Horvath A, Korde L, Greene MH, Libe R, Osorio P, Faucz FR, Raffin-Sanson ML, Tsang KM, Drori-Herishanu L, Patronas Y, Remmers EF, Nikita ME, Moran J, Greene J, Nesterova M, Merino M, Bertherat J, Stratakis CA. 2009. Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors. Cancer Res 69:5301-5306. http://dx.doi.org/10.1158/0008-5472.CAN-09-0884.
51. de Oliveira SK, Hoffmeister M, Gambaryan S, Muller-Esterl W, Guimaraes JA, Smolenski AP. 2007. Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. J Biol Chem 282:13656-13663. http://dx.doi.org/10.1074/jbc. M610942200.
52. Horvath A, Giatzakis C, Robinson-White A, Boikos S, Levine E, Griffin K, Stein E, Kamvissi V, Soni P, Bossis I, de Herder W, Carney JA, Bertherat J, Gregersen PK, Remmers EF, Stratakis CA. 2006. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res 66:11571-11575. http://dx.doi.org/10.1158/0008-5472.CAN-06-2914.
53. Libe R, Fratticci A, Coste J, Tissier F, Horvath A, Ragazzon B, Rene-Corail F, Groussin L, Bertagna X, Raffin-Sanson ML, Stratakis CA, Bertherat J. 2008. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin Cancer Res 14:4016-4024. http://dx.doi.org/10.1158/1078-0432.CCR-08-0106.
54. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-29. http://dx.doi.org/10.1038/75556.